Detection of GD3 ganglioside in primary melanomas depends on histopathologic procedures used for tumor preservation

Acta Dermatovenerologica Croatica

Volumn 17, Issue 3, 2009, Pages 209-216

  Debarbieux, Sébastien ^a,b   Popa, Iuliana ^a   Thomas, Luc ^a,b   Kanitakis, Jean ^a   Pirot, Fabrice ^a   Portoukalian, Jacques ^a   Haftek, Marek ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b HÔTEL DIEU   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

GD3 ganglioside; Immunohistochemistry; Melanoma; Retrospective study

Indexed keywords

GANGLIOSIDE GD3; GANGLIOSIDE GD3 ANTIBODY; MONOCLONAL ANTIBODY; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEGRADATION; FROZEN SECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MELANOMA; PRIMARY TUMOR; REPRODUCIBILITY; TISSUE PRESERVATION; TUMOR BIOPSY;

BIOPSY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOLOGICAL TECHNIQUES; FEASIBILITY STUDIES; FROZEN SECTIONS; GANGLIOSIDES; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 70349653686     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cheresh DA, Harper JR, Schulz G, Reisfeld RA. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci U S A 1984;81:5767-5771 (Pubitemid 14018484)
2. McKallip R, Li R, Ladisch S. Tumor gangliosides inhibit the tumor-specific immune response. J Immunol 1999;163:3718-3726 (Pubitemid 29450894)
3. Nakano J, Raj BK, Asagami C, Lloyd KO. Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics. J Invest Dermatol 1996;107:543-548 (Pubitemid 26338576)
4. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, Zeuner A, et al. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 1997;277:1652-1655 (Pubitemid 27446225)
5. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 1991;27:781-785
6. Carubia JM, Yu RK, Macala LJ, Kirkwood JM, Varga JM. Gangliosides of normal and neoplastic human melanocytes. Biochem Biophys Res Commun 1984;120:500-504 (Pubitemid 14149541)
7. Ravindranath MH, Tsuchida T, Morton DL, Irie RF. Ganglioside GM3:GD3 ratio as an index for the management of melanoma. Cancer 1991;67:3029-3035
8. Kanda S, Cochran AJ, Lee WR, Morton DL, Irie RF. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity. Int J Cancer 1992;52:682-687
9. Thomas CP, Buronfosse A, Fertil B, Portoukalian J. Surface expression of GD3 disialogangliosides in human melanoma cells is correlated to both metastatic potential in vivo and radiosensitivity in vitro. C R Acad Sci III 1995;318:1233-1238
10. Zebda N, Pedron S, Rebbaa A, Portoukalian J, Berthier-Vergnes O. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase). FEBS Lett 1995;362:161-164
11. Dippold WG, Dienes HP, Knuth A, Meyer zum Buschenfelde KH. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. Cancer Res 1985;45:3699-3705
12. Hersey P, Jamal O, Henderson C, Zardawi I, D'Alessandro G. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma. Int J Cancer 1988;41:336-343 (Pubitemid 18080784)
13. Urmacher C, Cordon-Cardo C, Houghton AN. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24. Am J Dermatopathol 1989;11:577-581 (Pubitemid 20016338)
14. Ohta S, Honda A, Tokutake Y, Yoshida H, Hanai N. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3. Cancer Immunol Immunother 1993;36:260-266 (Pubitemid 23069246)
15. Cerato E, Birkle S, Portoukalian J, Mezazigh A, Chatal JF, Aubry J. Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives. Hybridoma 1997;16:307-316 (Pubitemid 27410599)
16. Bouchon B, Portoukalian J, Bornet H. Sexspecific difference of the galabiosylceramide level in the glycosphingolipids of human thyroid. Biochim Biophys Acta 1985;836:143-152 (Pubitemid 15230705)
17. Popa I, Vlad CD, Bodennec J, Portoukalian J. Gangliosides are recovered on copolymer styrene-divinylbenzene columns. J Lipid Res 2002;43:1335-1340
18. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem 1963;10:613-623
19. Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G, Portoukalian J. A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res 2000;41:1524-1531 (Pubitemid 30743602)
20. Baruthio F, Quadroni M, Rüegg C, Mariotti A. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage. Proteomics 2008;8:4733-4747
21. Bennaceur K, Popa I, Chapman JA, Migdal C, Péguet-Navarro J, Touraine JL, et al. Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte- derived dendritic cells. 2009;19:576-582 Epub 2009 Feb 24
22. Ravindranath MH, Muthugounder S, Pressser N. Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient. Melanoma Res 2008;18:47-55. (Pubitemid 351628056)
23. Zeng G, Gao L, Birkle S, Yu RK. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res 2000;60:6670-6676
24. Ohkawa Y, Miyazaki S, Miyata M, Hamamura K, Furukawa K, Furukawa K. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3. Biochem Biophys Res Commun 2008;373:14-19
25. Garin-Chesa P, Beresford HR, Carrato-Mena A, Oettgen HF, Old LJ, Melamed MR, et al. Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems. Am J Pathol 1989;134:295-303. (Pubitemid 19063885)
26. Schwarz A, Futerman AH. Determination of the localization of gangliosides using anti-ganglioside antibodies: comparison of fixation methods. J Histochem Cytochem 1997;45:611-618 (Pubitemid 27175805)
27. Suzuki K. The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation. J Neurochem 1965;12:629-638